M
Masood Akhtar
Researcher at University of Wisconsin-Madison
Publications - 233
Citations - 8626
Masood Akhtar is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Tachycardia & Ventricular tachycardia. The author has an hindex of 47, co-authored 232 publications receiving 8491 citations. Previous affiliations of Masood Akhtar include Wisconsin Alumni Research Foundation & Medtronic plc.
Papers
More filters
Journal ArticleDOI
Automatic Implantable Cardioverter Defibrillators and Survival of Patients with Left Ventricular Dysfunction and Malignant Ventricular Arrhythmias
TL;DR: The automatic implantable cardioverter defibrillator is probably highly effective in preventing arrhythmic mortality even in high-risk patients and such treatment does not appear to significantly impair a patient's functional status.
Journal ArticleDOI
Sustained bundle branch reentry as a mechanism of clinical tachycardia.
TL;DR: The data suggest that sustained BBR is not an uncommon mechanism of tachycardia; it can be induced readily in the laboratory and is amendable to catheter ablation by the very nature of its circuit.
Journal ArticleDOI
Atrioverter: An Implantable Device for the Treatment of Atrial Fibrillation
Hein J.J. Wellens,Chu-Pak Lau,Berndt Lüderitz,Masood Akhtar,Albert L. Waldo,A. J. Camm,Carl Timmermans,Hung-Fat Tse,Werner Jung,Luc Jordaens,G. Ayers +10 more
TL;DR: With the Atrioverter, prompt and safe restoration of sinus rhythm is possible in patients with recurrent atrial fibrillation, and this system was evaluated in a prospective, multicenter study.
Journal ArticleDOI
Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group.
John P. DiMarco,William Miles,Masood Akhtar,Simon Milstein,Arjun D. Sharma,Edward V. Platia,Brian A. McGovern,Melvin M. Scheinman,William C. Govier +8 more
TL;DR: Adenosine in graded doses up to 12 mg rapidly and effectively terminates acute episodes of paroxysmal supraventricular tachycardia in which the atrioventricular node is an integral part of the re-entrant circuit.
Journal ArticleDOI
Comparison of Cardiac Pacing with Drug Therapy in the Treatment of Neurocardiogenic (Vasovagal) Syncope with Bradycardia or Asystole
Jasbir Sra,Mohammad Jazayeri,Boaz Avitall,Anwer Dhala,Sanjay Deshpande,Zalman Blanck,Masood Akhtar +6 more
TL;DR: In patients with neurocardiogenic syncope associated with bradycardia or asystole, drug therapy is often effective in preventing syncope, whereas artificial pacing is not.